Navigation Links
ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic,Testing of ANX-514 (Docetaxel Emulsion)

tere induced an anaphylactoid type reaction consistent with hypersensitivity reactions, including acute increases in blood histamine levels and decreased blood pressure. In contrast, no hypersensitivity reactions, including no elevations in histamine levels and no changes in blood pressure were observed following dosing with ANX-514.

ADVENTRX is continuing to conduct additional preclinical pharmacokinetic testing of ANX-514 to compare this product candidate with the approved version of the product, marketed under the brand name Taxotere. The Company currently plans to seek guidance from the FDA with respect to the appropriateness of a Section 505(b)(2) NDA regulatory path for ANX-514, and pending agreement on clinical protocol design with the FDA, initiate a marketing-enabling clinical trial of ANX-514 in 2007.

About ANX-514 (docetaxel emulsion)

ANX-514 is a novel nano-emulsion formulation of the chemotherapy drug docetaxel, a product marketed under the brand name Taxotere. ANX-514 is designed to eliminate the need for multi-day immunosuppressant premedication. ANX-514 is formulated without polysorbate 80 or other detergents and is intended to reduce the severity and/or incidence of hypersensitivity reactions. Docetaxel is an anti-cancer agent that acts by disrupting the cellular microtubular network that is essential for cell division. Immunosuppressant premedication is recommended for docetaxel therapy to reduce the incidence and severity of allergic reactions. Docetaxel is approved to treat breast, non-small cell lung, prostate, gastric and head and neck cancers. In connection with a Section 505(b)(2) NDA covering ANX-514, ADVENTRX must certify that all applicable Taxotere patents have expired prior to the manufacture, use or sale of ANX-514.

About Section 505(b)(2)

Section 505(b)(2) of the U.S. Food, Drug & Cosmetic Act (FDCA) allows the Food and Drug Administration (FDA) to approve a follow-on drug on the basis of data in
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... May 21, 2013  Zacks.com announces the list of ... Zacks Equity Research analysts discuss the latest news and ... featured in the blog include Actavis, Inc.,s (NYSE: ... SA (NYSE: TOT ), Petrobras (NYSE: PBR ... (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) ...
(Date:5/21/2013)... -- IsoRay, Inc. (AMEX: ISR ), ( http://www.isoray.com/ ... exclusive international distribution agreement with IASIS Medical for the ... Greece . IsoRay is a medical technology company ... for brain cancer, lung cancer, head and neck cancer, ... IASIS Medical is ideally suited to support IsoRay,s products, ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 2The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 3The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 4The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy 5IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 According to ... to Rethink the Use of Botox,” Botox injections ... since their approval in 2002 (Go to goo.gl/8iYbD). Although it ... quite popular with men. The injection makes facial wrinkles less ... Botox injection last for about three months. This means that ...
(Date:5/21/2013)... May 21, 2013 Global Proving Ground ... Bodybuilding.com, the largest online retailer of health and fitness ... reality-based sports show, Warrior Island. “We cast the ... Facebook & Twitter, with our unique social networking platform,” ... these elite fighters on an island in the Pacific ...
(Date:5/21/2013)... into genetic features of pulmonary fibrosis by physicians and ... may lead to improved treatment of this deadly lung ... JAMA . , The study found that a particular ... pulmonary fibrosis, a chronic progressive disease with a median ... study, researchers may want to consider including genetic testing ...
(Date:5/21/2013)... 21, 2013 The Las Vegas personal injury ... announce that Crawford Gates, a senior at Coronado High School, ... scholarship essay contest . As the winner of the essay ... contest started on Dec. 1, 2012 and ran through April ... submit a three-page minimum essay on “The Role of the ...
(Date:5/21/2013)... While North Carolina is synonymous with ... guides. Brunswick Plantation & Golf Resort is synonymous with ... to 27 holes of "Top10" championship golf. , ... knowing the Top 10 from an industry ... overwhelming task of selecting the course to play. Guests ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
... Oct. 17 ,PainCare Holdings, Inc. (Amex: ... providers,of pain-focused medical and surgical solutions and ... MDFI), a company specializing in,portable electronic medical ... of a partnership created to market the ...
... Help Pave the Way Toward Malaria ... Eradication U.S. Presidential Candidates Urged to Sustain and Expand ... Malaria Initiative, ... audacious goal - to reach a,day when no human being has malaria, and no mosquito ...
... Well Life Center in Mesa,Arizona, a leader in adult ... its "10 Healing Secrets to Health,& Longevity Workshop" on ... This session will teach you principals to achieve longevity ... tips on how to set,health goals that are inline ...
... Oct. 17 In its Statement on Risk ... Oncologists (SGO) provides concise guidelines, usable in a,primary ... women with a personal,or family history of breast, ... risk assessment. SGO,s Statement on Risk Assessment ...
... 17 Laser Energetics,Inc. (Pink Sheets: LNGT) announced ... BrightStar solid-state Alexandrite lasers, for a non-lethal laser,defense ... The BrightStar(TM) laser is part of the Company,s ... BrightStar(TM) laser was purchased,for experiments that are classified, ...
... be published in the October edition of Hypertension Research ... bark of the French maritime pine tree, helps individuals ... to an increase in blood flow and oxygen supply ... produced by the body, increases blood flow that serves ...
Cached Medicine News:Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 2Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 4Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 5Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 6Health News:Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication 2Health News:Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication 3Health News:Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer 2Health News:Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer 3Health News:Laser Energetics Delivers BrightStar(TM) Alexandrite Laser to Fortune 50 Defense Company 2Health News:New study: pine bark extract boosts nitric oxide production 2Health News:New study: pine bark extract boosts nitric oxide production 3
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Stylet tube, endotracheal, sterile, stainless steel, malleable, one size, overall length 13"(33cm)....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Medicine Products: